News & Events

CRYSTALSFIRST ESTABLISHES PARTNERSHIP WITH AKTTYVA THERAPEUTICS TO SUPPORT AI-POWERED DRUG DISCOVERY PROGRAMS Hamburg, Germany February 23, 2023 — CrystalsFirst, a leading provider of small-molecule drug

Chemical Space Docking: Odyssey to Unlock Relevant Compounds Advances in technology have led to a major breakthrough in chemical space exploration. By combining computational and

Magnet for the Needle in Haystack: “Crystal Structure First” Fragment Hits Unlock Active Chemical Matter Using Targeted Exploration of Vast Chemical Spaces Fragment-based drug discovery

Fragment-Based Drug Discovery — Hitting Targets Using the Right Chemistry and Expertise Alliances Fragment-Based Drug Discovery (FBDD) has gained significant attention and importance in recent

Unlocking chemical matter on scale Fragment-based drug discovery (FBDD) has become an indispensable resource for medicinal chemists in searching for lead candidates. To effectively evaluate